Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-09-19 Purchase | 2022-09-20 4:16 pm | Generation Bio Co. | GBIO | Rowland Charles A Jr Director | 15,750 | $5.26 | $82,845 | 191,797 (Direct) | View |
| 2022-09-15 Purchase | 2022-09-19 5:21 pm | Generation Bio Co. | GBIO | Rowland Charles A Jr Director | 50,628 | $5.4563 | $276,241 | 176,047 (Direct) | View |
| 2022-09-13 Purchase | 2022-09-15 4:07 pm | Generation Bio Co. | GBIO | Rowland Charles A Jr Director | 24,384 | $5.2249 | $127,404 | 125,419 (Direct) | View |
| 2022-08-01 Sale | 2022-08-03 9:48 pm | Nabriva Therapeutics plc | NBRV | Rowland Charles A Jr Director | 8,496 | $0.175 | $1,487 | 15,277 (Direct) | View |
| 2021-08-02 Sale | 2021-08-04 9:05 pm | Nabriva Therapeutics plc | NBRV | Rowland Charles A Jr Director | 777 | $1.2 | $932 | 23,773 (Direct) | View |
| 2021-01-11 Purchase | 2021-01-13 4:04 pm | Generation Bio Co. | GBIO | Rowland Charles A Jr Director | 20,408 | $24.5 | $499,996 | 101,035 (Direct) | View |
| 2020-12-17 Sale | 2020-12-18 4:09 pm | Blueprint Medicines Corp | BPMC | Rowland Charles A Jr Director | 10,909 | $117.82 | $1,285,298 | 3,562 (Direct) | View |
| 2020-11-02 Sale | 2020-11-04 5:18 pm | Blueprint Medicines Corp | BPMC | Rowland Charles A Jr Director | 10,000 | $98.9 | $989,011 | 9,084 (Direct) | View |
| 2020-06-16 Purchase | 2020-06-18 5:30 pm | Generation Bio Co. | GBIO | Rowland Charles A Jr Director | 30,000 | $19 | $570,000 | 80,627 (Direct) | View |
| 2019-06-20 Sale | 2019-06-24 8:08 pm | Blueprint Medicines Corp | BPMC | Rowland Charles A Jr Director | 11,818 | $95.15 | $1,124,462 | 10,000 (Direct) | View |
| 2018-12-24 Purchase | 2018-12-27 4:05 pm | Nabriva Therapeutics plc | NBRV | Rowland Charles A Jr Director | 53,000 | $1.31 | $69,430 | 53,000 (Direct) | View |
| 2018-05-29 Purchase | 2018-05-31 7:02 pm | Viking Therapeutics Inc. | VKTX | Rowland Charles A Jr Director | 30,000 | $5.16 | $154,800 | 30,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-01-03 Option Award | 2023-01-04 6:12 pm | 2024-01-03 2033-01-03 | Viking Therapeutics Inc. | VKTX | Rowland Charles A Jr Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:05 pm | N/A 2032-06-08 | Generation Bio Co. | GBIO | Rowland Charles A Jr Director | 19,200 | $0 | 19,200 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-08 4:05 pm | N/A 2032-06-06 | Orchard Therapeutics plc | ORTX | Rowland Charles A Jr Director | 46,000 | $0 | 46,000 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 7:11 pm | 2023-01-03 2032-01-03 | Viking Therapeutics Inc. | VKTX | Rowland Charles A Jr Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2021-07-28 Option Award | 2021-07-30 8:21 pm | N/A 2031-07-28 | Nabriva Therapeutics plc | NBRV | Rowland Charles A Jr Director | 52,500 | $0 | 59,550 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-17 5:02 pm | N/A 2031-06-15 | Orchard Therapeutics plc | ORTX | Rowland Charles A Jr Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-06-09 Option Award | 2021-06-11 4:09 pm | N/A 2031-06-08 | Generation Bio Co. | GBIO | Rowland Charles A Jr Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 4:16 pm | N/A 2031-06-02 | Blueprint Medicines Corp | BPMC | Rowland Charles A Jr Director | 6,750 | $0 | 10,312 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:42 pm | 2022-01-04 2031-01-04 | Viking Therapeutics Inc. | VKTX | Rowland Charles A Jr Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2020-12-17 Exercise | 2020-12-18 4:09 pm | N/A 2026-06-23 | Blueprint Medicines Corp | BPMC | Rowland Charles A Jr Director | 10,909 | $0 | 3,562 (Direct) | View |
| 2020-12-17 Exercise | 2020-12-18 4:09 pm | N/A N/A | Blueprint Medicines Corp | BPMC | Rowland Charles A Jr Director | 10,909 | $19.53 | 3,562 (Direct) | View |
| 2020-11-02 Exercise | 2020-11-04 5:18 pm | N/A 2025-03-22 | Blueprint Medicines Corp | BPMC | Rowland Charles A Jr Director | 10,000 | $0 | 9,084 (Direct) | View |
| 2020-11-02 Exercise | 2020-11-04 5:18 pm | N/A N/A | Blueprint Medicines Corp | BPMC | Rowland Charles A Jr Director | 10,000 | $9.46 | 9,084 (Direct) | View |
| 2020-07-29 Option Award | 2020-07-31 4:55 pm | N/A 2030-07-28 | Nabriva Therapeutics plc | NBRV | Rowland Charles A Jr Director | 52,500 | $0 | 105,500 (Direct) | View |
| 2020-06-24 Option Award | 2020-06-26 4:10 pm | N/A 2030-06-24 | Blueprint Medicines Corp | BPMC | Rowland Charles A Jr Director | 6,750 | $0 | 8,062 (Direct) | View |
| 2020-06-19 Exercise | 2020-06-23 4:15 pm | N/A N/A | Blueprint Medicines Corp | BPMC | Rowland Charles A Jr Director | 1,312 | $0 | 1,312 (Direct) | View |
| 2020-06-17 Option Award | 2020-06-19 4:18 pm | N/A 2030-06-16 | Orchard Therapeutics plc | ORTX | Rowland Charles A Jr Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2020-06-16 Conversion | 2020-06-18 5:30 pm | N/A N/A | Generation Bio Co. | GBIO | Rowland Charles A Jr Director | 140,050 | $0 | 80,627 (Direct) | View |
| 2020-06-11 Option Award | 2020-06-15 5:24 pm | N/A 2030-06-10 | Generation Bio Co. | GBIO | Rowland Charles A Jr Director | 52,000 | $0 | 52,000 (Direct) | View |
Ownership | 2020-06-11 8:35 pm | N/A N/A | Generation Bio Co. | GBIO | Rowland Charles A Jr Director | 0 | $0 | 93,088 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-03 7:55 pm | 2021-01-02 2030-01-02 | Viking Therapeutics Inc. | VKTX | Rowland Charles A Jr Director | 22,000 | $0 | 22,000 (Direct) | View |
Ownership | 2020-01-02 4:18 pm | N/A N/A | Orchard Therapeutics plc | ORTX | Rowland Charles A Jr Director | 0 | $0 | 127,324 (Direct) | View |
| 2019-07-31 Option Award | 2019-08-01 4:19 pm | N/A 2029-07-31 | Nabriva Therapeutics plc | NBRV | Rowland Charles A Jr Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2019-06-20 Exercise | 2019-06-24 8:08 pm | N/A 2025-03-22 | Blueprint Medicines Corp | BPMC | Rowland Charles A Jr Director | 11,818 | $0 | 10,000 (Direct) | View |
| 2019-06-20 Exercise | 2019-06-24 8:08 pm | N/A N/A | Blueprint Medicines Corp | BPMC | Rowland Charles A Jr Director | 11,818 | $9.46 | 10,000 (Direct) | View |
| 2019-06-19 Option Award | 2019-06-20 4:39 pm | N/A 2029-06-19 | Blueprint Medicines Corp | BPMC | Rowland Charles A Jr Director | 6,187 | $0 | 6,187 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-03 8:20 pm | 2020-01-02 2029-01-02 | Viking Therapeutics Inc. | VKTX | Rowland Charles A Jr Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2018-08-01 Option Award | 2018-08-02 5:53 pm | N/A 2028-08-01 | Nabriva Therapeutics plc | NBRV | Rowland Charles A Jr Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2018-06-21 Option Award | 2018-06-25 4:56 pm | N/A 2028-06-21 | Blueprint Medicines Corp | BPMC | Rowland Charles A Jr Director | 7,500 | $0 | 51,136 (Direct) | View |
| 2018-05-02 Option Award | 2018-05-04 4:06 pm | N/A 2028-05-02 | Nabriva Therapeutics plc | NBRV | Rowland Charles A Jr Director | 29,000 | $0 | 29,000 (Direct) | View |